HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1909 Cr | ₹1309 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.14 | 2.14 |
Manager | Dhruv Muchhal | Meeta Shetty |
ISIN Code | INF179KC1HL7 | INF277K016A9 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 0.68% | -0.46% |
6 Month | 12.34% | 10.75% |
1 Year | 9.21% | -0.17% |
3 Year | - | 24.41% |
5 Year | - | 17.24% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 5.23% | 3.9% |
1 Year | 15.8% | 9.27% |
3 Year | - | 22.51% |
5 Year | - | 19.09% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 29.56% | 10.55% |
3 Year | - | 18.34% |
5 Year | - | 15.18% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | - | 15.94% |
Sharp | - | 0.99% |
Beta | - | 0.98% |
Alpha | - | -0.12% |
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhruv Muchhal | Meeta Shetty |
Total AUM | ₹520687 Cr | ₹17847 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 8.17 | 4.61 |
Mid Cap | 27.19 | 35.03 |
Small Cap | 35.64 | 31.95 |
Large Cap | 29 | 28.41 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.1 | 2.56 |
Basic Materials | 2.44 | 1.44 |
Healthcare | 96.46 | 94.45 |
Financial Services | - | 1.56 |
Top Comparisons
Invesco India Dynamic Equity Fund - Growth
3Y Returns13.24%
Quant Dynamic Asset Allocation Fund Regular - Growth
3Y Returns0%
Tata Overnight Fund-Regular Plan-Growth
3Y Returns6.36%
UTI - Overnight Fund - Regular Plan - Growth Option
3Y Returns6.41%
ICICI Prudential Banking and PSU Debt Fund - Growth
3Y Returns7.48%
Sundaram Banking and PSU Fund - Regular Plan - Growth
3Y Returns7.42%
Bajaj Finserv Money Market Fund Regular - Growth
3Y Returns0%
Baroda BNP Paribas Money Market Fund-Regular Plan - Growth
3Y Returns7.14%